Scion NeuroStim
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Scion NeuroStim sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
Scion NeuroStim: 9 sponsored US clinical trials, none currently recruiting.
Scion NeuroStim sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. The most-studied condition in this pipeline is Parkinson's Disease and Parkinsonism, with 1 trials.
Top-decile sponsor footprint
Scion NeuroStim ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
SHARPEN - Parkinson's Disease Dementia
NCT05987540
STEM-PD Open Label Extension (OLE)
NCT04799418
STEM-Parkinson's Disease
NCT04797611
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
NCT02991430
Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia
NCT02270866
Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes
NCT02130401
A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease
NCT02134795
A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache
NCT01899040
Neurostimulation Device for Treatment of Migraine Headache
NCT01630044
Therapeutic Areas
How the Scion NeuroStim archive is shaped
9 indexed studies, none listed as recruiting (0% open); 4 completed (44%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Parkinson's Disease and Parkinsonism (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Scion NeuroStim: archived-pipeline peers nationwide
Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Scion NeuroStim sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 archived trials
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Scion NeuroStim page
9 registered trials is a research-attention snapshot, not an endorsement of Scion NeuroStim or any single study.
- None of Scion NeuroStim's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Parkinson's Disease and Parkinsonism is the condition Scion NeuroStim studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinson's Disease and Parkinsonism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Scion NeuroStim pipeline card: 9 registered trials from official public datasets.Report a data error.